These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8877708)

  • 21. rhG-CSF in healthy donors: mobilization of peripheral hemopoietic progenitors and effect on peripheral blood leukocytes.
    Sica S; Rutella S; Di Mario A; Salutari P; Rumi C; Ortu la Barbera E; Etuk B; Menichella G; D'Onofrio G; Leone G
    J Hematother; 1996 Aug; 5(4):391-7. PubMed ID: 8877714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dendritic cell-based vaccines in the setting of peripheral blood stem cell transplantation: CD34+ cell-depleted mobilized peripheral blood can serve as a source of potent dendritic cells.
    Choi D; Perrin M; Hoffmann S; Chang AE; Ratanatharathorn V; Uberti J; McDonagh KT; Mulé JJ
    Clin Cancer Res; 1998 Nov; 4(11):2709-16. PubMed ID: 9829733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allogeneic transplantation of peripheral blood progenitor cells.
    Schmitz N
    Nouv Rev Fr Hematol (1978); 1995; 37(6):377-9. PubMed ID: 8907635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two consecutive courses of rh-G-CSF-mobilized peripheral blood stem cells for primary marrow alloengraftment failure: case report.
    Martino M; Pucci G; Irrera G; Messina G; Morabito F; Iacopino P
    Haematologica; 1996; 81(5):464-7. PubMed ID: 8952162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunobiology of allogeneic peripheral blood mononuclear cells mobilized with granulocyte-colony stimulating factor.
    Gyger M; Stuart RK; Perreault C
    Bone Marrow Transplant; 2000 Jul; 26(1):1-16. PubMed ID: 10918400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic graft-versus-host disease after granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation: the role of donor T-cell dose and differentiation.
    MacDonald KP; Rowe V; Filippich C; Johnson D; Morris ES; Clouston AD; Ferrara JL; Hill GR
    Biol Blood Marrow Transplant; 2004 Jun; 10(6):373-85. PubMed ID: 15148491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allogeneic peripheral blood stem cell rescue of late graft failure after bone marrow transplantation in patients with aplastic anemia.
    Chung IJ; Lee JJ; Park MR; Kook H; Cho SH; Hwang TJ; Kim HJ
    J Korean Med Sci; 2002 Aug; 17(4):468-74. PubMed ID: 12172040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
    Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk assessment in haematopoietic stem cell transplantation: stem cell source.
    Urbano-Ispizua A
    Best Pract Res Clin Haematol; 2007 Jun; 20(2):265-80. PubMed ID: 17448961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of granulocyte colony-stimulating factor in mobilization and transplantation of peripheral blood progenitor and stem cells .
    Haas R; Murea S
    Cytokines Mol Ther; 1995 Dec; 1(4):249-70. PubMed ID: 9384679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The biology and clinical uses of blood stem cells.
    To LB; Haylock DN; Simmons PJ; Juttner CA
    Blood; 1997 Apr; 89(7):2233-58. PubMed ID: 9116266
    [No Abstract]   [Full Text] [Related]  

  • 32. Use of G-CSF-stimulated marrow in allogeneic hematopoietic stem cell transplantation settings: a comprehensive review.
    Chang YJ; Huang XJ
    Clin Transplant; 2011; 25(1):13-23. PubMed ID: 20626760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allogeneic transplantation of G-CSF mobilized peripheral blood stem cells from unrelated donors: a retrospective analysis.
    Bornhäuser M; Theuser C; Soucek S; Hölig K; Klingebiel T; Blau W; Fauser A; Runde V; Schwinger W; Rutt C; Ehninger G
    Haematologica; 2000 Aug; 85(8):839-47. PubMed ID: 10942931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors influencing reconstitution by bone marrow transplantation.
    van Bekkum DW; Wielenga JJ; van Gils F; Wagemaker G
    Prog Clin Biol Res; 1990; 352():479-91. PubMed ID: 1698302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Donor lymphocyte infusions for relapse after allogeneic transplantation: when, if and for whom?
    Chang YJ; Huang XJ
    Blood Rev; 2013 Jan; 27(1):55-62. PubMed ID: 23261066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GM-CSF-based mobilization effect in normal healthy donors for allogeneic peripheral blood stem cell transplantation.
    Sohn SK; Kim JG; Seo KW; Chae YS; Jung JT; Suh JS; Lee KB
    Bone Marrow Transplant; 2002 Jul; 30(2):81-6. PubMed ID: 12132046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pilot study of allogeneic G-CSF-stimulated bone marrow transplantation: harvest, engraftment, and graft-versus-host disease.
    Ostronoff M; Ostronoff F; Souto Maior P; Matias C; Calixto R; Sucupira A; Domingues M; Florencio R; Tagliari C
    Biol Blood Marrow Transplant; 2006 Jul; 12(7):729-33. PubMed ID: 16785062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of granulocyte colony stimulating factor at content of donor lymphocytes collected for cellular immunotherapy.
    Arat M; Arslan O; Gürman G; Dalva K; Ozcan M; Uğur A; Ilhan O
    Transfus Apher Sci; 2004 Feb; 30(1):9-15. PubMed ID: 14746816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of normal donors with recombinant growth factors for transplantation of allogeneic blood stem cells.
    Bensinger WI; Buckner CD; Rowley S; Storb R; Appelbaum FR
    Bone Marrow Transplant; 1996 Mar; 17 Suppl 2():S19-21. PubMed ID: 8722328
    [No Abstract]   [Full Text] [Related]  

  • 40. Increased risk of lethal graft-versus-host disease-like syndrome after transplantation into NOD/SCID mice of human mobilized peripheral blood stem cells, as compared to bone marrow or cord blood.
    Gorin NC; Piantadosi S; Stull M; Bonte H; Wingard JR; Civin C
    J Hematother Stem Cell Res; 2002 Apr; 11(2):277-92. PubMed ID: 11983099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.